-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Globus Medical, Raises Price Target to $120

Benzinga·05/08/2026 16:56:15
Listen to the news
RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and raises the price target from $115 to $120.